Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institutes of Health (NIH) | NIH |
Not provided
Not provided
Not provided
Not provided
This study will examine the level of toxicity of e-cigarette use compared to smokers and nonsmokers including inflammation markers, toxicant and carcinogen exposure. Additionally, the study will look at the effect of varying voltage levels for e-cigarette users.
In this observational study, e-cigarette users, smokers, and non-users of e-cigarette or tobacco products (up to 134 per group) will be recruited from the Minneapolis-St. Paul area. This research will be conducted at the Tobacco Research Programs at the University of Minnesota. Subjects are screened for eligibility over the phone. If eligible after the phone screen, participants will be invited to attend orientation screening visit in the clinic where consent will be obtained and subjects will complete forms about their tobacco and e-cigarette use and medical history. Subjects who eligible will be asked to return for six visits over the course of six months.
At these appointments, subjects will provide biological specimen samples (buccal cells, urine and blood). Saliva will be collected before and after a smoking or vaping session. Non-users will only have 1 saliva collection.
Subjects will be asked for information pertaining to and e-cigarette and tobacco use and overall health.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Smokers | |||
| E-cigarette users | |||
| Non-smokers |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| DNA Adducts | Formation of Formaldehyde DNA Adducts in oral cells before and after smoking or vaping | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Urinary 8-iso-PGF-2α | Stability of Urinary 8-iso-PGF-2α (biomarkers of oxidative damage) over a 6-month sample period | 6 months |
| Urinary PGEM | Stability of Urinary PGEM (biomarker of inflammation) over a 6-month sample period |
Not provided
Inclusion Criteria:
Meet criteria for 1 of three groups:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects will be recruited locally within reasonable distance from the University of Minnesota.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Stephen Hecht, Phd | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55414 | United States |
Not provided
| ID | Term |
|---|---|
| D012907 | Smoking |
| D000073865 | Cigarette Smoking |
| D000072137 | Vaping |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D000073869 | Tobacco Smoking |
| D064424 | Tobacco Use |
Not provided
Not provided
Not provided
Not provided
Not provided
Buffy Coat, Serum, Plasma, Urine, Buccal Cells, Saliva
| 6 months |
| C-reactive protein | Stability of C-reactive protein in serum (biomarker of inflammation) over a 6-month sample period | 6 months |
| TNE | Total Nicotine Equivalents (nicotine exposure) over a 6-month sample period | 6 months |